Check-Cap (MBAI) EBT Growth (3y) (2017 - 2024)
Check-Cap (MBAI) EBT Growth (3y) (2017 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 212.96 Bn | 208.90 Bn | 8.34 Bn | 10.40% |
| 2 | Danaher | 139.30 Bn | 134.95 Bn | 3.61 Bn | -1.90% |
| 3 | Idexx Laboratories | 46.15 Bn | 45.95 Bn | 779.09 Mn | 13.42% |
| 4 | Agilent Technologies | 39.40 Bn | 37.59 Bn | 990.00 Mn | 2.67% |
| 5 | Iqvia Holdings | 38.20 Bn | 36.12 Bn | 1.44 Bn | -7.07% |
| 6 | Natera | 37.79 Bn | 36.69 Bn | 696.04 Mn | 14.73% |
| 7 | Illumina | 28.65 Bn | 27.49 Bn | 770.00 Mn | 70.10% |
| 8 | Mettler Toledo International | 28.40 Bn | 28.35 Bn | 650.22 Mn | 3.19% |
| 9 | Quest Diagnostics | 26.32 Bn | 25.69 Bn | 1.03 Bn | 9.13% |
| 10 | Check-Cap | 8.16 Mn | 6.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 74.22% |
| Dec 31, 2023 | -161.08% |
| Sep 30, 2023 | -10.54% |
| Jun 30, 2023 | 33.54% |
| Mar 31, 2023 | 12.23% |
| Dec 31, 2022 | 3.16% |
| Sep 30, 2022 | 10.73% |
| Jun 30, 2022 | 12.74% |
| Mar 31, 2022 | 23.16% |
| Dec 31, 2021 | 21.23% |
| Sep 30, 2021 | 16.20% |
| Jun 30, 2021 | 13.82% |
| Mar 31, 2021 | 18.82% |
| Dec 31, 2020 | 27.14% |
| Sep 30, 2020 | 14.92% |
| Jun 30, 2020 | 0.71% |
| Mar 31, 2020 | 8.95% |
| Dec 31, 2019 | 16.94% |
| Sep 30, 2019 | 25.92% |
| Jun 30, 2019 | 19.02% |